A schedule of events for MALDI-Mass Spectrometry Imaging of Drug Metabolism is provided below for your convenience.

This is a one-day conference scheduled for Tuesday, April 8, 2014 at the University of Maryland School of Pharmacy, located at 20 N. Pine Street in Baltimore, MD. The conference is open to the public. Download a printer-friendly version of the agenda here.

9:00-10:00 a.m. Registration and Light Breakfast
10:00-10:15 a.m. Welcome and Introduction
10:15-10:55 a.m. MALDI Imaging Mass Spectrometry: A View of Biology and Chemistry in Drug Development
Stephen Castellino, PhD
US Director of Structal ID DMPK
GlaxoSmith Kline
10:55-11:35 a.m. Mass Spectrometry Imaging in Drug Development
Per Andren, PhD
Senior Lecturer, Department of Pharmaceutical Biosciences
University of Uppsala
Uppsala, Sweden
11:35-12:15 p.m. MALDI-MS Tissue Imaging in Infectious Disease Research: Exploring Alternative Fixation Methods for the Inactivation of Pathogens
Lisa Cazares, PhD
Proteomic Scientist
Army Research Institute of Infectious Disease (USAMRIID)
12:15-1:15 p.m. Lunch
1:15-1:55 p.m. Mass Spectrometry Imaging Applications to Tuberculosis Drug Discovery and Development
Brendan Prideaux, PhD
Visiting Researcher
The Public Health Research Institute (PHRI)
Rutgers New Jersey Medical School
1:55-2:35 p.m. MALDI-Mass Spectrometry Imaging in the Development of Medical Countermeasures Against Radiological Threat
Maureen Kane, PhD
Assistant Professor
Department of Pharmaceutical Sciences
University of Maryland School of Pharmacy
2:35-3:15 p.m. Imaging Mass Spectrometry: Applications Supporting Drug Discovery and Development
Michelle L. Reyzer, PhD
Research Assistant Professor of Biochemistry
Vanderbilt University
3:15-3:45 p.m. Panel and Audience Discussion
Topic: Status of MALDI-MSI Adoption as a Drug Development Tool
3:45-4:00 p.m. Closing Remarks